Rescue therapy for refractory status asthmaticus with updosed omalizumab adjusted for IgE level, body weight and effect
Status asthmaticus is a life-threatening condition with a high mortality rate of up to 10.3% [1].Milger et al. recently described a rapid clinical improvement and a reduction in serum IgE levels in a patient with status asthmaticus who received salvage therapy with omalizumab [2]. This treatment is...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2022-01-01
|
| Series: | Respiratory Medicine Case Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2213007122000363 |